![]() ![]() | Grignet, C. (28 January 2025). Nettoyage et désinfection en Médecine Vétérinaire - cadre réglementaire belge [Paper presentation]. 13ème Biosecurity day, Liège, Belgium. |
![]() ![]() | Bricmont, N., Benchimol, L., POIRRIER, A.-L., Grignet, C., Seaton, C., Chilvers, M. A., Seghaye, M.-C., Louis, R., Lefèbvre, P., & KEMPENEERS, C. (2020). Nasal Brushing Sampling and Processing using Digital High Speed Ciliary Videomicroscopy - Adaptation for the COVID-19 Pandemic. Journal of Visualized Experiments, (165). doi:10.3791/61949 ![]() |
![]() ![]() | Grignet, C. (22 February 2018). Comment prévenir le risque biologique en laboratoire ou animalerie de recherche ? [Paper presentation]. Jeudis de la santé au travail, Liège, Belgium. |
![]() ![]() | Humblet, M.-F., Vanderschueren, P., Grignet, C., Cassart, D., Korsak Koulagenko, N., & Saegerman, C. (2017). Observations as a way to assess the compliance of veterinary students with biosecurity procedures. Revue Scientifique et Technique. Office International des Epizooties, 36 (3). doi:10.20506/rst36.3.2712 ![]() |
![]() ![]() | Grignet, C. (26 January 2016). Travail en laboratoire de niveau de confinement 2 (L2) [Paper presentation]. Biosecurity day - 4ème édition - Faculté de Médecine vétérinaire de l'U.Lg. |
![]() ![]() | Humblet, M.-F., Vanderschueren, P., Grignet, C., Cassart, D., Korsak Koulagenko, N., & Saegerman, C. (May 2014). Observance as a tool to assess the compliance of vet students to biosecurity rules in a veterinary necropsy room and at a slaughterhouse [Poster presentation]. 17th Annual European Biosafety Association Conference, Ghent, Belgium. |
![]() ![]() | Grignet, C. (2013). La protection de l’environnement et les installations classées en Belgique [Paper presentation]. Journées du Groupement National pour la Prévention des Risques Professionnels dans l’Enseignement Supérieur français, Liège, Belgium. |
![]() ![]() | Grignet, C. (2013). La gestion du risque biologique en Belgique [Paper presentation]. Journées du Groupement National pour la Prévention des Risques Professionnels dans l’Enseignement Supérieur français, Liège, Belgium. |
![]() ![]() | Grignet, C. (27 February 2013). Gestion du risque biologique en laboratoires : démarche et enjeux [Paper presentation]. Séminaires de la recherche - Faculté de Médecine vétérinaire ULG. |
![]() ![]() | Grignet, C. (2008). The practical challenges of the Biosafety officer : interacting with the user. In The Biosafety Professional: roles and interactions in a complex network. |
![]() ![]() | Drion, P., Grignet, C., Ectors, F., & Rentier, B. (26 September 2006). Mise en route des animaleries GIGA souris et zébrafish: biosécurité, guide du chercheur et complémentarité avec l'Animalerie Centrale ULG - CHU [Paper presentation]. Séminaires du CBIG - GIGA, CHU, Liège, Belgium. |
Drion, P., & Grignet, C. (2006). Implementing BSL II & BSL III activities in an existing facility : the case of the Animal facility of the CHU at University of Liège, Belgium " [Paper presentation]. Colloque Scientifique Tecnilab, Milano, Italy. |
![]() ![]() | Grignet, C., Noël, A., Foidart, J.-M., & Calberg-Bacq, C. M. (2005). Identification of factors important for the success of suicide gene therapy after a comparative study of Varicella zoster and Herpes simplex viral thymidine kinases efficacy on breast cancer cells. Cellular and Molecular Biology, 51 (1), 37-48. doi:10.1170/T596 ![]() |
![]() ![]() | Masson, V., Devy, L., Grignet, C., Berndt, S., Bajou, K., Blacher, S., Roland, G., Chang, Y., Fong, T., Carmeliet, P., Foidart, J.-M., & Noël, A. (28 October 2002). Mouse Aortic Ring Assay: A New Approach of the Molecular Genetics of Angiogenesis. Biological Procedures Online, 4, 24-31. doi:10.1251/bpo30 ![]() |
![]() ![]() | Devy, L., Blacher, S., Grignet, C., Bajou, K., Masson, V., Gerard, R. D., Gils, A., Carmeliet, G., Carmeliet, P., Declerck, P. J., Noël, A., & Foidart, J.-M. (February 2002). The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB Journal, 16 (2), 147-54. doi:10.1096/fj.01-0552com ![]() |
![]() ![]() | Grignet, C., Hajitou, A., Noël, A., & Foidart, J.-M. (2002). Attempt to enhance the suicide gene therapy agaisnt breast cancer cells by using connexin 43 gene. Acta Clinica Belgica, 57 (2), 99. |
![]() ![]() | Hajitou, A., Grignet, C., Devy, L., Berndt, S., Blacher, S., Deroanne, C., Bajou, K., Fong, T., Chiang, Y. W., Foidart, J.-M., & Noël, A. (2002). The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. FASEB Journal, 16, 1802-1804. doi:10.1096/fj.02-0109fje ![]() |
![]() ![]() | Hajitou, A., Sounni, N. E., Devy, L., Grignet, C., Lewalle, J.-M., Li, H., Deroanne, C., Lu, H., Colige, A., Nusgens, B., Frankenne, F., Maron, A., Yeh, P., Perricaudet, M., Chang, Y., Soria, C., Calberg-Bacq, C.-M., Foidart, J.-M., & Noël, A. (15 April 2001). Down-Regulation of Vascular Endothelial Growth Factor by Tissue Inhibitor of Metalloproteinase-2: Effect on in Vivo Mammary Tumor Growth and Angiogenesis. Cancer Research, 61 (8), 3450-7. ![]() |
Grignet, C., Cool, V., Baudson, N., Degrève, B., Balzarini, J., De Leval, L., Debrus, S., Velu, T., & Calberg-Bacq, C.-M. (2000). Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2’-deoxyuridine (BVDU) and its arabinosyl derivative,(E)-5-(2-bromovinyl)-1-b-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase. Cancer Gene Therapy, 7, 215-223. doi:10.1038/sj.cgt.7700108 ![]() |
Grignet, C., Cool, V., Baudson, N., Velu, T., & Calberg-Bacq, C.-M. (2000). The role of cellular and prodrug-associated factors in the bystander effect induced by the Varicella zoster and the Herpes simplex virus thymidine kinases in suicide gene therapy. Cancer Gene Therapy, 7, 1456-1468. doi:10.1038/sj.cgt.7700250 ![]() |
Grignet, C., Cool, V., Baudson, N., Velu, T., Rentier, B., & Calberg-Bacq, C.-M. (1999). Factors involved in the bystander effect induced by Varicella zoster and Herpes simplex viral thymidine kinase suicide gene therapy. Journal of Gene Medicine, 1, 46. |
Grignet, C., & Calberg-Bacq, C.-M. (1997). Potential of Varicella zoster virus thymidine kinase as a suicide gene in breast cancer cells. Gene Therapy, 4, 560-569. doi:10.1038/sj.gt.3300435 ![]() |
Grignet, C., & Calberg-Bacq, C.-M. (1995). A dicistronic vector carrying Varicella zoster virus thymidine kinase confers BVDU sensitivity to breast cancer cells in vitro and in vivo. Cancer Gene Therapy, 2, 246. |